These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34414867)

  • 1. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer.
    Xu W; Wang B; Cai Y; Chen J; Meng E; Guo C; Zhou G; Yuan C
    Curr Pharm Des; 2021; 27(39):4100-4106. PubMed ID: 34414867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of LncRNA FENDRR in Multiple Cancers: A Review.
    Fazaeli H; Sheikholeslami A; Ghasemian F; Amini E; Sheykhhasan M
    Curr Mol Med; 2023 May; 23(7):606-629. PubMed ID: 35579154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA FENDRR inhibits migration and invasion of cutaneous malignant melanoma cells.
    Chen XE; Chen P; Chen S; Lu J; Ma T; Shi G; Sheng L
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32134466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FENDRR Expression Correlates with Tumor Immunogenicity.
    Munteanu MC; Sethuraman SN; Singh MP; Malayer J; Ranjan A
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FENDRR: A pivotal, cancer-related, long non-coding RNA.
    Zheng Q; Zhang Q; Yu X; He Y; Guo W
    Biomed Pharmacother; 2021 May; 137():111390. PubMed ID: 33761608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis.
    Zhang G; Wang Q; Zhang X; Ding Z; Liu R
    Biomed Pharmacother; 2019 Oct; 118():109309. PubMed ID: 31545237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA
    Zhao X; Wu J; Li Y; Ye F; Wang C
    Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
    Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
    J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Functional Role of Oncogenic LncRNA BCAR4 for Cancer Outcome.
    Wang B; Xu W; Cai Y; Liu K; Wu J; Guo C; Yuan C
    Curr Pharm Des; 2021; 27(39):4107-4113. PubMed ID: 34086548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.
    Pan H; Yu T; Sun L; Chai W; Liu X; Yan M
    Transl Cancer Res; 2020 Jun; 9(6):3946-3959. PubMed ID: 35117761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
    Gong F; Dong D; Zhang T; Xu W
    Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CASC15: A Tumor-Associated Long Non-Coding RNA.
    Wang B; Xu W; Cai Y; Guo C; Zhou G; Yuan C
    Curr Pharm Des; 2021; 27(1):127-134. PubMed ID: 32962611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis.
    Xu W; Wang B; Cai Y; Guo C; Liu K; Yuan C
    Curr Pharm Des; 2021; 27(20):2337-2343. PubMed ID: 33106136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FENDRR inhibits proliferation and invasion of hepatocellular carcinoma by down-regulating glypican-3 expression.
    Wang B; Xian J; Zang J; Xiao L; Li Y; Sha M; Shen M
    Biochem Biophys Res Commun; 2019 Jan; 509(1):143-147. PubMed ID: 30573358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FENDRR Sponges miR-424-5p to Inhibit Cell Proliferation, Migration and Invasion in Colorectal Cancer.
    Cheng C; Li H; Zheng J; Xu J; Gao P; Wang J
    Technol Cancer Res Treat; 2020; 19():1533033820980102. PubMed ID: 33356998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FENDRR Upregulation Promotes Hepatic Carcinoma Cells Apoptosis by Targeting miR-362-5p Via NPR3 and p38-MAPK Pathway.
    Qian G; Jin X; Zhang L
    Cancer Biother Radiopharm; 2020 Nov; 35(9):629-639. PubMed ID: 32251605
    [No Abstract]   [Full Text] [Related]  

  • 20. N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma.
    Shen J; Feng XP; Hu RB; Wang H; Wang YL; Qian JH; Zhou YX
    Lab Invest; 2021 Jun; 101(6):775-784. PubMed ID: 33692441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.